
51 - 200 employés
🏥 Santé
🍽️ Alimentation et boissons
🧬 Biotechnologie
🔥 Financement dans la dernière année
💰 €30 000 000 Post-IPO Secondary - DBV Technologies en 2025-10
Healthcare • Food & Beverage • Biotechnology
DBV Technologies est une société biopharmaceutique mondiale en phase clinique, développant une immunothérapie épicutanée pour traiter les allergies alimentaires et d'autres maladies à médiation immunitaire. Fondée par des pédiatres, l'entreprise fait progresser sa technologie brevetée de patch VIASKIN® à travers des essais cliniques, y compris des études de Phase 3 pour un patch contre l'allergie à l'arachide (DBV712) et des programmes en phase initiale pour l'allergie au lait (DBV135), dans le but de rééduquer le système immunitaire en utilisant une exposition contrôlée de la peau à des antigènes.
🕒 il y a 2 mois
🏖️ New Jersey – Distant
💵 $200 000 - $240 000 / an
⏰ Temps Plein
🔴 Expert
👔 Directeur
👻 Score fantôme 17%
🗣️🇺🇸🇬🇧 Anglais requis
Améliorez vos chances d'obtenir un entretien en vérifiant votre score de CV avant de postuler.

51 - 200 employés
🏥 Santé
🍽️ Alimentation et boissons
🧬 Biotechnologie
🔥 Financement dans la dernière année
💰 €30 000 000 Post-IPO Secondary - DBV Technologies en 2025-10
Healthcare • Food & Beverage • Biotechnology
DBV Technologies est une société biopharmaceutique mondiale en phase clinique, développant une immunothérapie épicutanée pour traiter les allergies alimentaires et d'autres maladies à médiation immunitaire. Fondée par des pédiatres, l'entreprise fait progresser sa technologie brevetée de patch VIASKIN® à travers des essais cliniques, y compris des études de Phase 3 pour un patch contre l'allergie à l'arachide (DBV712) et des programmes en phase initiale pour l'allergie au lait (DBV135), dans le but de rééduquer le système immunitaire en utilisant une exposition contrôlée de la peau à des antigènes.
• Serve as a scientific expert and key point of contact between DBV Technologies and external payer and population health decision-makers • Communicate evidence-based information on VIASKIN Peanut’s value proposition and pediatric food allergy health outcomes • Engage national and regional payers, PBMs, IDNs, employers, and population health key opinion leaders • Communicate efficacy, safety, patch wear-time, and real-world relevance to support coverage and formulary decisions • Conduct educational programs, scientific presentations, and value-evidence discussions • Establish and maintain relationships with medical and pharmacy directors, payer decision-makers, professional societies, and patient advocacy organizations • Disseminate health outcomes data, real-world evidence, health economic models, and budget-impact analyses • Collaborate with Market Access, Medical Affairs, Value & Access, Commercial, and Field Reimbursement teams • Design outcomes-based analytics using internal data sources and external vendors such as IQVIA, Optum Insights, and Komodo • Train internal teams on outcomes data and value evidence • Address unsolicited payer inquiries in accordance with regulations and company policy • Support investigator-initiated studies, real-world evidence generation, and other research initiatives • Contribute to strategic plans for health outcomes research, value-evidence communication, and payer engagement • Integrate health outcomes strategies into product launch, access, and commercialization plans • Ensure communications and interactions comply with regulatory requirements, legal guidance, and company policies
• PharmD, M.D., or Ph.D. in a health sciences–related field required • Master’s in pharmacoepidemiology, epidemiology, or health economics preferred • Minimum of eight (8) years working in the pharmaceutical, biotechnology, or healthcare industry • Minimum of five (5) years in a HEOR or payer-facing scientific function supporting product launches with U.S. Market Access teams • Experience spanning medical and scientific affairs, outcomes research, clinical practice, academic, or U.S. managed-markets settings • Therapeutic experience in allergy/immunology, pediatrics, and/or rare disease preferred; familiarity with the food allergy treatment landscape is a strong advantage • Strong understanding of health outcomes research, epidemiology, and health economics • Demonstrated experience engaging national and regional payers, PBMs, IDNs, and other organized customers in a scientific or value-evidence capacity • Expertise in economic modeling, budget-impact analysis, data analysis, and interpreting clinical and real-world data • Knowledge of industry trends, healthcare policies, and regulations impacting HEOR • Understanding of therapeutic areas, disease mechanisms, treatment landscapes, and market dynamics • Excellent written, verbal, communication, and presentation skills • Strong proficiency with regulatory guidelines and requirements related to HEOR studies and payer scientific exchange • Understanding of compliance and ethical considerations in research and payer engagement • Ability to build relationships with external stakeholders, thought leaders, and academic HEOR experts • Ability to collaborate cross-functionally, manage multiple projects, prioritize tasks, meet deadlines, and adapt to changing priorities • Proficiency in resource allocation, budget management, and project planning • Comfort operating in an ambiguous, fast-paced, pre-commercial environment • Ability to articulate clearly and conduct presentations with large and small audiences
Postuler Maintenant🕒 il y a 2 mois
HEOR Director managing strategic healthcare quality and evidence generation for Boehringer Ingelheim products. Overseeing cross-functional collaboration and leading the HEOR strategy for multiple therapeutic areas.
🇺🇸 États-Unis – Télétravail
💵 $200 000 - $316 000 / an
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Director of HEOR responsible for leading healthcare quality strategies in obesity and liver disease. Collaborating across functions to support brand value propositions in the US market.
🇺🇸 États-Unis – Télétravail
💵 $200 000 - $316 000 / an
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
🇺🇸 États-Unis – Télétravail
💵 $140 000 - $150 000 / an
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Director translating POS and consumer panel data into actionable growth insights for CPG clients at Circana. Driving consultative sales, strategic recommendations, and client relationships.
🗣️🇺🇸🇬🇧 Anglais requis
🕒 il y a 2 mois
Director, Ecosystems managing partner strategies to drive growth at Palo Alto Networks. Collaborating across teams to execute strategic Go-To-Market initiatives and optimize partner performance.
🇺🇸 États-Unis – Télétravail
💵 $356 000 - $415 250 / an
💰 €1 000 000 Seed Round - Morta Security en 2013-02
⏰ Temps Plein
🔴 Expert
👔 Directeur
🦅 Parrain de Visa H1B
🗣️🇺🇸🇬🇧 Anglais requis